Krsnaa Diagnostics Future Growth
Future criteria checks 5/6
Krsnaa Diagnostics is forecast to grow earnings and revenue by 35.5% and 24.6% per annum respectively. EPS is expected to grow by 35.8% per annum. Return on equity is forecast to be 14.1% in 3 years.
Key information
35.5%
Earnings growth rate
35.8%
EPS growth rate
Healthcare earnings growth | 27.6% |
Revenue growth rate | 24.6% |
Future return on equity | 14.1% |
Analyst coverage | Low |
Last updated | 14 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 12,320 | 1,682 | 1,071 | 2,813 | 2 |
3/31/2026 | 10,227 | 1,184 | 336 | 1,864 | 3 |
3/31/2025 | 7,524 | 825 | -168 | 1,532 | 2 |
9/30/2024 | 6,812 | 692 | -1,147 | 439 | N/A |
6/30/2024 | 6,503 | 601 | N/A | N/A | N/A |
3/31/2024 | 6,196 | 568 | -1,695 | 243 | N/A |
12/31/2023 | 5,866 | 570 | N/A | N/A | N/A |
9/30/2023 | 5,464 | 577 | -677 | 842 | N/A |
6/30/2023 | 5,138 | 625 | N/A | N/A | N/A |
3/31/2023 | 4,871 | 621 | -651 | 763 | N/A |
12/31/2022 | 4,621 | 611 | N/A | N/A | N/A |
9/30/2022 | 4,505 | 638 | -1,125 | 477 | N/A |
6/30/2022 | 4,358 | 610 | N/A | N/A | N/A |
3/31/2022 | 4,555 | 684 | -38 | 1,284 | N/A |
12/31/2021 | 4,431 | 395 | N/A | N/A | N/A |
3/31/2021 | 3,965 | 1,849 | 357 | 1,026 | N/A |
12/31/2020 | 3,694 | 1,307 | 256 | 963 | N/A |
3/31/2020 | 2,584 | -1,120 | -389 | 378 | N/A |
3/31/2019 | 2,092 | -621 | -415 | 583 | N/A |
3/31/2018 | 1,076 | -602 | N/A | 391 | N/A |
3/31/2017 | 569 | -39 | N/A | 622 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 543328's forecast earnings growth (35.5% per year) is above the savings rate (6.7%).
Earnings vs Market: 543328's earnings (35.5% per year) are forecast to grow faster than the Indian market (17.9% per year).
High Growth Earnings: 543328's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 543328's revenue (24.6% per year) is forecast to grow faster than the Indian market (10.5% per year).
High Growth Revenue: 543328's revenue (24.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 543328's Return on Equity is forecast to be low in 3 years time (14.1%).